Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
All content for Brain Trash: Psychiatry from DSM to Dumpster Fire is the property of Maria Ingalla & Tabitha Arey and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
Send us questions here! Why Autistic Brains Struggle with Sleep | Brain Trash Podcast In this episode of Brain Trash, Maria Ingalla and Tabitha Arey unpack the science and lived experiences behind sleep struggles in autistic individuals. From melatonin dysregulation and altered sleep architecture to sensory processing and behavioral cycles—this episode digs into why sleep is so often misunderstood in neurodivergent care. Whether you’re a provider, parent, or navigating your own neurodivergent...
Brain Trash: Psychiatry from DSM to Dumpster Fire
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
